AtaGenix
Technical Service

Chemiluminescent Antibody Development

Introduction

Immunoassay is an important means of clinical diagnosis and treatment (e.g. virus, hormone, tumor marker and other types of detection). Chemiluminescence immunoassay is the latest immunoassay technology developed after radioimmunoassay, fluorescence immunoassay and enzyme immunoassay, which has the advantages of high sensitivity, no radioactive contamination, wide detection range and good stability of markers, and it is the main form of development of immunoassay field.

Chemiluminescence immunoassay includes two parts: immune reaction and chemiluminescence. Using bio-immunity technology to realize the specific combination of the substance to be tested, the luminescent marker and the target substance, so that it luminesces in an alkaline environment, and the light energy released corresponds monotonically with the concentration of the substance to be tested, so that the concentration of the substance to be tested can be obtained indirectly through the measurement of the light energy. At present, the popular target substances are immunomagnetic particles, i.e., ferrite particles encapsulated with antibodies or antigens, which can be bound by a magnetic field to facilitate the separation of substances; luminescent markers are obtained by labeling a chemiluminescent agent (acridinium ester or isoluminol) on an antibody.


Schematic Diagram of Direct Chemiluminescence Immunoassay Principle


AtaGenix provides development technical services for chemiluminescent monoclonal antibody pairs, using acridine ester direct luminescence system, chemiluminescent reagents in the luminescence immunoassay process without enzyme catalytic effect, directly involved in the luminescence reaction. They have the characteristic group of luminescence in their chemical structure, and can directly label antigen or antibody.


Chemiluminescent Immunoassay Analyzer

Instrument Performance Parameters

Testing speed: 180 tests/H; Detection principle: magnetic particles direct chemiluminescence; Marker: acridine ester; Testing mode: random, batch, emergency; Sample position: 40; Reagent position: 9; Carrying contamination rate: ≤ 10-5; Precision: CV ≤ 3%.

Advantages

1.5 protein expression platforms to promote antigen preparation

2.Experience in independent research and development of chemiluminescence reagent kits

3. Customized experimental solutions

4. Direct chemiluminescence is fast

5. Good reagent stability


Automatic Chemiluminescence Platform in Operation

Contents

Projects

Contents

Time Frame

Deliverables

Chemiluminescent Antibody Pair Development

Antigen preparation: peptide/protein

Immunization: Mouse (optional rat)

Fusion & screening

Subcloning & screening

Production of monoclonal antibodies (5-10 strains)

Antibody labeling with biotin & acridine ester

Pairing experiment: recombinant protein

Experiment report

  4-6 Months

Purified monoclonal antibody 2mg each (customized quantity)

Hybridoma cell line (at least 1 pair of cell lines)

Antigen sample 200ug

Experiment report

Chemiluminescence Kit Development

Raw material screening

Core process validation & determination

Reaction system optimization

Calibrators/QCs

Determination of kit performance metrics

Reference range determination

Stability studies

  3 Months

Experiment report

Case Study

ng/ml

Photometric Values

Photometric Value - Blank Value

100

426261

421539

50

169161

164439

25

76614

71892

12.5

35564

30842

6.25

18569

13847

3.125

10703

5981

1.5625

6484

1762

0

4722

0